Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1984 1
1985 1
1992 2
1994 2
1995 1
1996 2
1997 2
1998 3
1999 5
2000 5
2001 19
2002 5
2003 4
2004 7
2005 3
2006 4
2007 3
2008 5
2009 4
2010 4
2011 2
2012 2
2013 4
2014 6
2015 3
2017 3
2018 6
2019 2
2020 3
2022 2
2023 2
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of food allergy: Oral immunotherapy, biologics, and beyond.
Sindher SB, Hillier C, Anderson B, Long A, Chinthrajah RS. Sindher SB, et al. Among authors: hillier c. Ann Allergy Asthma Immunol. 2023 Jul;131(1):29-36. doi: 10.1016/j.anai.2023.04.023. Epub 2023 Apr 25. Ann Allergy Asthma Immunol. 2023. PMID: 37100276 Free PMC article. Review.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
International Multiple Sclerosis Genetics Consortium (IMSGC); Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC); Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofont… See abstract for full author list ➔ International Multiple Sclerosis Genetics Consortium (IMSGC), et al. Among authors: hillier c. Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29. Nat Genet. 2013. PMID: 24076602 Free PMC article.
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J. Blackstone J, et al. Among authors: hillier c. BMJ Open. 2024 Sep 16;14(9):e086414. doi: 10.1136/bmjopen-2024-086414. BMJ Open. 2024. PMID: 39284697 Free PMC article.
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial.
Pal S, Chataway J, Swingler R, Macleod MR, Carragher NO, Hardingham G, Selvaraj BT, Smith C, Wong C, Newton J, Lyle D, Stenson A, Dakin RS, Ihenacho A, Colville S, Mehta AR, Stallard N, Carpenter JR, Parker RA, Keerie C, Weir CJ, Virgo B, Morris S, Waters N, Gray B, MacDonald D, MacDonald E, Parmar MKB, Chandran S; MND SMART Investigators. Pal S, et al. Lancet Neurol. 2024 Nov;23(11):1097-1107. doi: 10.1016/S1474-4422(24)00326-0. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307154 Free article. Clinical Trial.
Functional human tissue assays.
Hillier C, Bunton D. Hillier C, et al. Drug Discov Today. 2007 May;12(9-10):382-8. doi: 10.1016/j.drudis.2007.03.012. Epub 2007 Apr 5. Drug Discov Today. 2007. PMID: 17467574 Review.
Neural scene representation and rendering.
Eslami SMA, Jimenez Rezende D, Besse F, Viola F, Morcos AS, Garnelo M, Ruderman A, Rusu AA, Danihelka I, Gregor K, Reichert DP, Buesing L, Weber T, Vinyals O, Rosenbaum D, Rabinowitz N, King H, Hillier C, Botvinick M, Wierstra D, Kavukcuoglu K, Hassabis D. Eslami SMA, et al. Among authors: hillier c. Science. 2018 Jun 15;360(6394):1204-1210. doi: 10.1126/science.aar6170. Science. 2018. PMID: 29903970
Psychological interventions for multiple sclerosis.
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Thomas PW, et al. Among authors: hillier c. Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004431. doi: 10.1002/14651858.CD004431.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437487 Free PMC article.
ER-Golgi network--a future target for anti-cancer therapy.
Wlodkowic D, Skommer J, McGuinness D, Hillier C, Darzynkiewicz Z. Wlodkowic D, et al. Among authors: hillier c. Leuk Res. 2009 Nov;33(11):1440-7. doi: 10.1016/j.leukres.2009.05.025. Leuk Res. 2009. PMID: 19595459 Free PMC article. Review.
The clinical relevance of adrenomedullin: a promising profile?
Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJ. Bunton DC, et al. Among authors: hillier c. Pharmacol Ther. 2004 Sep;103(3):179-201. doi: 10.1016/j.pharmthera.2004.07.002. Pharmacol Ther. 2004. PMID: 15464589 Review.
116 results